Abstract: To provide a piezoelectric body film that can suppress decrease in the piezoelectric constant d31, a method of producing a piezoelectric body film, and a piezoelectric body device. A piezoelectric body film comprising a fluororesin as a piezoelectric material, the fluororesin containing, as a main constituent unit, a repeating unit derived from vinylidene fluoride, a piezoelectric constant d31 of the piezoelectric body film being 20 pC/N or greater, and an extrapolated onset temperature at start of shrinkage determined by TMA measurement being not lower than 90° C. and not higher than 115° C. The difference between piezoelectric constants d31 measured before and after heating the piezoelectric body film at 100° C. for 24 hours relative to the piezoelectric constant d31 before the heating for 24 hours is 20% or less.

Abstract: The present invention relates to a fiber branch structure for spatial optical communication for transmitting information by emitting communication light. The fiber branch structure is provided with: a light emitter configured to emit communication light; a light emission controller configured to control the light emitter; an optical fiber configured to transmit the light emitted from the light emitter; a distributor configured to distribute the light, the distributer being optically coupled to an output terminal of the optical fiber; and an optical fiber group optically coupled to a plurality of output terminals of the distributor. According to the present invention, a communication area can be established without blind spots. That is, the fiber branch structure for spatial optical communication according to the present invention includes an optical fiber group optically coupled to a plurality of output terminals of the distributor.

Abstract: Provided is a stand capable of supporting an electronic device and improving the degree of freedom in appearance of the electronic device. A stand (1) is a stand for supporting an electronic device (90) having a lower exterior panel (92B) with a curved lower surface. The stand (1) has a stand main body (B) that is located, in plan view, inside an outer circumferential edge of the lower exterior panel (92B) and that has supporting surfaces (11a and 11b) to make contact with the lower surface. Also, the stand (1) has an arm (27) that extends from the stand main body (B) toward the outer circumferential edge of the lower exterior panel (92B) of the electronic device (90) and that has engagement sections (27A and 27B) to engage with an exterior member of the electronic device (90).

Abstract: The present invention relates to a fiber branch structure for spatial optical communication for transmitting information by emitting communication light. The fiber branch structure is provided with: a light emitter configured to emit communication light; a light emission controller configured to control the light emitter; an optical fiber configured to transmit the light emitted from the light emitter; a distributor configured to distribute the light, the distributer being optically coupled to an output terminal of the optical fiber; and an optical fiber group optically coupled to a plurality of output terminals of the distributor. According to the present invention, a communication area can be established without blind spots. That is, the fiber branch structure for spatial optical communication according to the present invention includes an optical fiber group optically coupled to a plurality of output terminals of the distributor.

Abstract: An optical communication device 1 is provided with: a plurality of light-receiving elements 11 each configured to receive light and output a light detection signal; a plurality of optical fibers 13 provided to correspond to the plurality of light-receiving elements 11, respectively, the plurality of optical fibers each being configured to guide the light to the corresponding light-receiving element 11; a plurality of amplifiers 18 provided to correspond to the plurality of light-receiving elements 11, respectively, the plurality of amplifiers each being configured to generate optical communication information by performing signal processing on the light detection signal; a light intensity information collection unit 25 configured to collect intensity of the light received by each of the plurality of optical fibers 13 as light intensity information; an optical fiber identification unit 27 configured to identify the optical fiber 13 that is receiving relatively strong light out of the plurality of optical fiber

Abstract: A game device in which a first comparison unit compares an exemplary model posture (posture that is supposed to be adopted by a player) at a reference time and a posture of the player indicated by posture data acquired by a posture data acquiring unit at a compared time. A second comparison unit executes at least one of: a comparison between a different posture from the exemplary model posture at the reference time and the posture of the player indicated by the posture data acquired at the compared time; and a comparison between the exemplary model posture at the reference time and a different posture from the posture of the player indicated by the posture data acquired at the compared time. An output control unit causes an output based on a comparison between results from the first and second comparison units.

Abstract: It is an object of the present invention to detect a change in the metabolism of a glycoprotein having an ?2,6-sialyl residue, which is contained in blood, so as to provide an agent and a method for diagnosing sporadic Alzheimer's disease. The present invention provides an agent for diagnosing Alzheimer's disease, which comprises lectin used for detecting an ?2,6-sialyl residue-containing glycoprotein.

Abstract: A game device of a computer game includes plural unit games, each of which can be completed when a requirement for completion is satisfied.

Abstract: A game device in which a first comparison unit compares an exemplary model posture (posture that is supposed to be adopted by a player) at a reference time and a posture of the player indicated by posture data acquired by a posture data acquiring unit at a compared time. A second comparison unit executes at least one of: a comparison between a different posture from the exemplary model posture at the reference time and the posture of the player indicated by the posture data acquired at the compared time; and a comparison between the exemplary model posture at the reference time and a different posture from the posture of the player indicated by the posture data acquired at the compared time. An output control unit causes an output based on a comparison between results from the first and second comparison units.

Abstract: It is an object of the present invention to detect a change in the metabolism of a glycoprotein having an ?2,6-sialyl residue, which is contained in blood, so as to provide an agent and a method for diagnosing sporadic Alzheimer's disease. The present invention provides an agent for diagnosing Alzheimer's disease, which comprises lectin used for detecting an ?2,6-sialyl residue-containing glycoprotein.

Abstract: A game device of a computer game includes plural unit games, each of which can be completed when a requirement for completion is satisfied.

Abstract: The present invention provides the mPrickle gene which encodes a protein present in mammalian PSD fractions. The mPrickle protein is localized in synapses, and binds to the scaffold protein PSD-95. Precipitation of endogenous mPrickle using an anti-mPrickle antibody results in the coprecipitation of NMDA receptors, and thus, mPrickle can be used in drug delivery systems that target NMDA receptors. NMDA receptors are closely related to learning and memory, and are also suggested to be involved in mental disorders. Thus, in the future, mPrickle is expected to be applicable to the diagnosis and/or treatment of neurodegenerative diseases associated with learning/memory, such as mental deterioration and dementia.

Abstract: The present invention provides the mPrickle gene which encodes a protein present in mammalian PSD fractions. The mPrickle protein is localized in synapses, and binds to the scaffold protein PSD-95. Precipitation of endogenous mPrickle using an anti-mPrickle antibody results in the coprecipitation of NMDA receptors, and thus, mPrickle can be used in drug delivery systems that target NMDA receptors. NMDA receptors are closely related to learning and memory, and are also suggested to be involved in mental disorders. Thus, in the future, mPrickle is expected to be applicable to the diagnosis and/or treatment of neurodegenerative diseases associated with learning/memory, such as mental deterioration and dementia.

Abstract: The invention described herein provide beverages which have excellent palatability and are limited in calorie content and a sweetener composition having the same characteristics, which contain sucralose and acesulfame K.

Abstract: The invention described herein improves the suppression or the control of a flavor in sucralose-containing beverages by incorporating aspartame into the beverage. Thus the present invention provides a low-calorie beverage, containing at least one flavoring ingredient, aspartame and sucralose, where the aspartame:sucralose weight ratio is from 1:1 to 10:1.

Abstract: This application provides a novel protein, nectin-3 having an amino acid sequence of any of SEQ ID NO: 2, 4 or 6, which belongs to a nectin protein family participating in cell-cell adhesion. It also provides a polynucleotide that codes for the nectin-3 and has a base sequence of any of SEQ ID NO: 1, 3 or 5; a recombinant vector having the polynucleotide; and an antibody against the protein nectin-3. The protein nectin-3 provides important information for clarifying all aspects of the molecular mechanism in cell-cell binding systems, and, in addition, it leads to the possibility of clarifying the mechanism of, for example, humectation and metastasis of carcinoma, and is expected to be applicable to diagnosis of carcinoma for its malignancy and to a method for treating cases with carcinoma and also to development of medicines for carcinoma.